Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Atrisone completes pivotal phase III acne studies

Jan. 8, 2004

Topical tacrolimus reported effective for oral lichen planus and facial psoriasis

Dec. 30, 2003

PMA filing commences for OrCel for venous leg ulcers

Dec. 30, 2003

Connetics submits NDA for Actiza

Dec. 30, 2003

PVAC development for psoriasis discontinued

Dec. 30, 2003

Disappointing results for HuMax-CD4 in phase IIb psoriasis trial

Dec. 17, 2003

Finacea approved in E.U. as topical treatment of papulopustular rosacea

Dec. 17, 2003

Fujisawa launches pediatric Protopic in Japan

Dec. 16, 2003

OrCel achieves primary and secondary endpoints in venous leg ulcer study

Dec. 15, 2003

Novactyl seeks licensing partner for PCL-016

Dec. 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...